Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer.
David E Gerber, Jeffrey R Infante, Michael S Gordon, Sarah B Goldberg, Miguel Martín, Enriqueta Felip, Maria Martinez Garcia, Joan H Schiller, David R Spigel, Julie Cordova, Valerie Westcott, Yulei Wang, David S Shames, YounJeong Choi, Robert Kahn, Randall C Dere, Divya Samineni, Jian Xu, Kedan Lin, Katie Wood, Stephanie Royer-Joo, Vanessa Lemahieu, Eva Schuth, Anjali Vaze, Daniel Maslyar, Eric W Humke, Howard A Burris
Clinical cancer research : an official journal of the American Association for Cancer Research 2020;26(2):364-372